VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $621,000 | -24.5% | 3,483 | -6.0% | 0.01% | -28.6% |
| Q2 2015 | $823,000 | -49.2% | 3,705 | -54.6% | 0.01% | -50.0% |
| Q1 2015 | $1,620,000 | +42.6% | 8,155 | +2.7% | 0.01% | +40.0% |
| Q4 2014 | $1,136,000 | +11.0% | 7,937 | +1.9% | 0.01% | +11.1% |
| Q3 2014 | $1,023,000 | +5.9% | 7,792 | +1.7% | 0.01% | 0.0% |
| Q2 2014 | $966,000 | +59.1% | 7,662 | +66.5% | 0.01% | 0.0% |
| Q1 2014 | $607,000 | -2.6% | 4,602 | -13.3% | 0.01% | 0.0% |
| Q4 2013 | $623,000 | +20.7% | 5,310 | +7.5% | 0.01% | 0.0% |
| Q3 2013 | $516,000 | -5.0% | 4,941 | -21.7% | 0.01% | -10.0% |
| Q2 2013 | $543,000 | – | 6,307 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |